Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptimmune Therapeutics PLC

0.3239
+0.01896.20%
Post-market: 0.34200.0181+5.59%19:33 EDT
Volume:3.94M
Turnover:1.21M
Market Cap:83.32M
PE:-1.08
High:0.3301
Open:0.2860
Low:0.2666
Close:0.3050
Loading ...
Aug 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 02, 2024

Major Issues Report

Form 8-K - Current report
Jul 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 16, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Major Issues Report

Form 8-K - Current report
Apr 12, 2024

Major Issues Report

Form 8-K - Current report
Apr 02, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 26, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mar 06, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 06, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 31, 2024

Major Issues Report

Form 8-K - Current report
Jan 30, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals